Kronox Lab Sciences Ltd

Kronox Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kronox Lab Sciences Ltd

₹ 163 6.10%
05 Jul - close price
kronoxlabsciences.com BSE: 544187 NSE: KRONOX
About

Incorporated in 2008, Kronox Lab Sciences Limited manufactures high-purity specialty fine chemicals for diverse end-user industries.[1]

Key Points

Business Profile[1] The company manufactures High Purity Speciality Fine Chemicals for numerous industries, including pharmaceuticals, scientific and laboratory research, nutraceuticals, biotech, agrochemicals, personal care, metallurgy, and animal health.

Website BSE NSE
  • Market Cap ₹ 605 Cr.
  • Current Price ₹ 163
  • High / Low ₹ 174 / 144
  • Stock P/E 28.4
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE 51.6 %
  • ROE 38.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 39.2%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Dec 2023 Mar 2024
21.47 20.71 22.18
17.48 14.40 14.33
Operating Profit 3.99 6.31 7.85
OPM % 18.58% 30.47% 35.39%
0.14 0.42 0.83
Interest 0.00 0.00 0.00
Depreciation 0.30 0.30 0.29
Profit before tax 3.83 6.43 8.39
Tax % 36.55% 24.57% 29.92%
2.44 4.84 5.88
EPS in Rs 0.66 1.30 1.58
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
50 62 82 96 90
39 48 63 74 62
Operating Profit 12 15 20 22 28
OPM % 23% 24% 24% 23% 32%
1 1 1 2 2
Interest 0 0 0 0 0
Depreciation 1 2 2 2 1
Profit before tax 12 13 18 22 29
Tax % 27% 26% 26% 26% 25%
9 10 14 17 21
EPS in Rs 343.60 403.73 565.56 4.48 5.75
Dividend Payout % 0% 0% 0% 0% 9%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 13%
TTM: -6%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 30%
TTM: 29%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 39%
Last Year: 38%

Balance Sheet

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 0 0 0 37 37
Reserves 23 27 40 8 29
0 4 3 0 0
11 7 13 9 8
Total Liabilities 34 38 57 54 74
6 9 11 16 26
CWIP 0 0 0 0 0
Investments 0 0 0 0 0
29 28 45 38 47
Total Assets 34 38 57 54 74

Cash Flows

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
4 11 9 20 17
-4 -3 -8 -6 -17
-0 -7 -1 -13 0
Net Cash Flow 0 1 1 1 0

Ratios

Figures in Rs. Crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 110 90 114 71 72
Inventory Days 70 58 58 61 74
Days Payable 102 69 89 52 50
Cash Conversion Cycle 78 79 84 80 96
Working Capital Days 100 100 128 83 143
ROCE % 50% 51% 51%

Shareholding Pattern

Numbers in percentages

Jun 2024
74.21%
2.97%
6.81%
16.01%
No. of Shareholders 31,450

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

No data available.

DRHP